Transcriptional evidence for the "Reverse Warburg Effect" in human
                        breast cancer tumor stroma and metastasis: Similarities with oxidative stress,

















































































































































































Recently, we identified a loss of stromal caveolin-1 
(Cav-1) as a novel biomarker for the cancer-associated 
fibroblast phenotype in human breast cancers [1].  More 
specifically, when fibroblasts were isolated from human 
breast cancers, 8 out of 11 patients showed >2-fold 
reduction in Cav-1 protein expression, relative normal 
matched fibroblasts prepared from the same patients [1].  
Furthermore, detailed phenotypic analysis of mammary 
fibroblasts derived from Cav-1 (-/-) null mice revealed 
that they share numerous properties with cancer-
associated fibroblasts, such as constitutively active 
TGFbeta signaling, and that they have the ability to 
promote normal mammary epithelial cells to undergo an 
EMT (epithelial-mesenchymal transition) [2]. 
 
To determine if loss of stromal Cav-1 has prognostic 
value, we performed a series of independent biomarker 
studies [3,4].  Using a cohort of 160 breast cancer 
patients, with nearly 20 years of follow-up data, we 
showed that a loss of stromal Cav-1 (in the fibroblast 
compartment) is a powerful single independent 
predictor early tumor recurrence, lymph node 
metastasis, tamoxifen-resistance, and poor clinical 
outcome [4].  As the prognostic value of a loss of 
stromal Cav-1 was independent of epithelial marker 
status, it appears that a loss of Cav-1 has predictive 
value in all the different epithelial subtypes of human 
breast cancer, including ER+, PR+, HER2+, and triple-
negative patients [4].  The high predictive value of a 
loss of stromal Cav-1 was also independently validated 
by another independent laboratory, using a second 
independent breast cancer patient cohort [5].  
 
A loss of stromal Cav-1 also appears to play a role in 
tumor initiation and progression [6]. Using a DCIS 
patient cohort, in which patients were treated with wide-
excision, but without any chemo- or radio-therapy, we 
also evaluated the prognostic value of stromal Cav-1 
[6].  In this DCIS patient cohort, a loss of stromal Cav-1 
was specifically associated with DCIS recurrence and 
invasive progression.  100% of the patients with a loss 
of stromal Cav-1 underwent recurrence, and 80% of 
these patients progressed to invasive disease, namely 
















also independently obtained in human prostate cancers, 
where a loss of stromal Cav-1 was specifically 
associated with advanced prostate cancer, tumor 
progression, and metastatic disease [7].  
 
To begin to understand the mechanism(s) underlying 
the lethality of a loss of Cav-1 in cancer-associated 
fibroblasts, we turned to Cav-1 (-/-) deficient mice as a 
model system.  
 
For this purpose, we isolated bone marrow derived 
stromal cells from WT and Cav-1 (-/-) deficient mice, as 
cancer-associated fibroblasts are thought to evolve from 
mesenchymal stem cells [8]. These cells were then 
subjected to unbiased proteomic and genome-wide 
transcriptional analysis.  Interestingly, proteomic 
analysis revealed the upregulation of i) 8 myo-fibroblast 
markers (including vimentin, calponin, and 
tropomyosin), ii) 8 glycolytic enzymes (including 
PKM2 and LDHA), and iii) 2 markers of oxidative 
stress (peroxiredoxin1 and catalase) [8]. The glycolytic 
phenotype of Cav-1 (-/-) null stromal cells was also 
supported by transcriptional analysis, as most of the 
proteins that were found to be upregulated by 
proteomics, were also transcriptionally upregulated [8]. 
Based on these findings, we proposed a new model to 
understand the role of the Warburg effect (“aerobic 
glycolysis”) in tumor metabolism. We hypothesized that 
glycolytic cancer-associated fibroblasts promote tumor 
growth by the secretion of energy-rich metabolites 
(such as pyruvate and lactate) that could then be taken 
up by adjacent epithelial cancer cells, where they would 
be incorporated into the tumor cell’s TCA cycle, 
leading to enhanced ATP production [8]. This would 
provide a feed-forward mechanism by which glycolytic 
fibroblasts could promote tumor growth, progression, 
and metastasis. Because the Warburg effect was 
previously thought to be largely confined to tumor cells, 
and not to the cancer-associated fibroblast 
compartment, we have termed this new idea “The 
Reverse Warburg Effect” [8].  
 
In order to determine which transcriptional programs 
are activated in Cav-1 (-/-) stromal cells, we performed 
an extensive bioinformatics analysis of our genome-
wide profiling data [9]. This informatics analysis 
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ROS production and oxidative stress [9]. This, in turn, 
results in the activation of key transcription factor, such 
as HIF and NF-kB, which can then drive aerobic 
glycolysis and inflammation in the tumor micro-
environment [9]. This could provide a molecular basis 
for understanding the lethality of a loss of stromal Cav-
1 in human breast cancer patients.  
 
Here, we have used a bioinformatics approach to 
determine whether similar “Warburg-like” transcrip-
tional profiles exist in the tumor stroma isolated from 
human breast cancers.  For this purpose, we analyzed an 
existing data set in which the tumor stroma was isolated 
away from adjacent breast cancer cells using laser-
capture micro-dissection [10].  We now provide new 
evidence for the existence of the “Reverse Warburg 
Effect” in human tumor stroma from breast cancer 
patients. More specifically, the tumor stroma of human 
breast cancers shows a transcriptional shift towards 
oxidative stress, DNA damage/repair, inflammation, 
hypoxia, and aerobic glycolysis, supporting with the 
“Reverse Warburg Effect”. Consistent with the idea that 
oxidative stress in the tumor stroma is a driving factor 
in promoting tumor progression and metastasis, we also 
show that the tumor stroma of human breast cancers 
overlaps significantly with the transcriptional profiles 
associated with Alzheimer’s brain disease.   
 
Finally, the “Reverse Warburg Effect” is strikingly 
similar to the theory of “Neuon-Glia Metabolic 
Coupling” [11-18], which was proposed more than 10 
years ago to explain metabolic changes associated with 
normal synaptic transmission, which may be 
exacerbated during neuronal stress and neuronal 
degeneration, as in Alzheimer’s disease. In “Neuron-
Glia Metabolic Coupling”, astrocytes undergo aerobic 
glycolysis, secrete energy-rich metabolites (pyruvate 
and lactate), and neurons then take up these metabolites 
and use them in the neuronal TCA cycle to generate 
high amounts of ATP. Thus, we propose that “The 
Reverse Warburg Effect” we observe could also be 
more broadly termed “Epithelial-Stromal Metabolic 
Coupling”.  
 
As such, tumors may be initiating a survival mechanism 
that is normally used by the brain during stress. 
Interestingly, myofibroblasts and mesenchymal stem 
cells are known to often express GFAP (glial fibrillary 
acidic protein) [19-21], an intermediate filament protein 
that is thought to be relatively specific for astrocytes in 
the central nervous system. Here, we see that GFAP is 
upregulated in the “tumor stroma” and in the stroma of 
“metastasis-prone” breast cancer patients. Thus, 
possible similarities between astrocytes and myo-





Transcriptional comparison of Cav-1 (-/-) stromal 
cells with human breast cancer stroma  
 
Previously, we subjected Cav-1 (-/-) bone marrow 
derived stromal cells, and their wild-type counter-parts 
to genome-wide transcriptional profiling [8].  Because 
such a large number of gene transcript levels are 
changed, we focused on the gene transcripts that are 
upregulated. We speculated that these Cav-1 (-/-) 
stromal gene profiles might also overlap with the 
transcriptional stromal profiles obtained from human 
breast cancers.   
 
To test this hypothesis directly, we obtained the 
transcriptional profiles of a large data set of human 
breast cancer patients [10] whose tumors were subjected 
to laser-capture micro-dissection, to selectively isolate 
the tumor stroma. Based on this data set [10], we then 
generated three human breast cancer stromal genes lists: 
 
1)  Tumor Stroma vs. Normal Stroma List- Compares 
the transcriptional profiles of tumor stroma obtained 53 
patients to normal stroma obtained from 38 patients. 
Genes transcripts that were consistently upregulated in 
tumor stroma were selected and assigned a p-value, 
with a cut-off of p <0.05 (contains 6,777 genes) 
(Supplementary Table 1).  
 
2)  Recurrence Stroma List- Compares the transcript-
tional profiles of tumor stroma obtained from 11 
patients with tumor recurrence to the tumor stroma of 
42 patients without tumor recurrence. Genes transcripts 
that were consistently upregulated in the tumor stroma 
of patients with recurrence were selected and assigned a 
p-value, with a cut-off of p <0.05 (contains 3,354 genes) 
(Supplementary Table 2). 
 
3) Lymph-node (LN) Metastasis Stroma List- Compares 
the transcriptional profiles of tumor stroma obtained 
from 25 patients with LN metastasis to the tumor 
stroma of 25 patients without LN metastasis. Genes 
transcripts that were consistently upregulated in the 
tumor stroma of patients with LN metastasis were 
selected and assigned a p-value, with a cut-off of p 
<0.05 (contains 1,182 genes) (Supplementary Table 3). 
 
These three gene lists were then individually intersected 
with the transcriptional profile of Cav-1 (-/-) null 
stromal cells [8]. The results of these intersections are 
presented in Figure 1, as Venn diagrams. Most important- 
   








































ly, significant overlap was seen with all three gene lists. 
Greater than 2,000 genes were common between the 
Cav-1 (-/-) stromal gene list and the gene transcripts 
upregulated in breast cancer tumor stroma (p = 1.6 x 10
-
3).  Also, more than 1,000 gene transcripts were 
common between the Cav-1 (-/-) stromal gene list and 
the gene transcripts upregulated in the breast cancer 
tumor stroma of patients with tumor recurrence (p = 1 x 
10
-3). Finally, nearly 500 genes were commonly 
upregulated between Cav-1 (-/-) stromal cells and the 
breast cancer tumor stroma of patients with LN 
metastasis (p = 4.6 x 10
-6).  Thus, the transcriptional 
profiles of Cav-1 (-/-) stromal cells are most   
ignificantly related to the tumor stroma of patients with 
LN-metastasis. Independently, our previous data 
demonstrated that a loss of stromal Cav-1 protein 
expression (by immuno-histochemistry) in human 
breast cancers is specifically associated with a 2.6-fold 
increase in the number of tumor cell positive lymph 
nodes (LN-metastasis) [3, 4].   
 
The top 100 most significant gene transcripts for all 
three human breast cancer stromal gene lists, 
including their transcriptional intersection with Cav-1 
(-/-) stromal cells, is included in Supplementary 
Tables 3, 4, and 5.  
 
As Cav-1 (-/-) stromal cells are a genetic model of 
activated myofibroblasts [2] which biosynthetically 
secrete more collagen, and fibrosis is a critical risk 
factor for poor clinical outcome in human breast 
cancer patients [3], we also looked at the potential 
overlap been the expression of collagen gene 
transcripts (See Table 1). Thirty-five collagen gene 
transcripts were specifically upregulated in tumor 
stroma; 16 were upregulated in “recurrence-prone” 
stroma; and only 1 was upregulated in “metastasis-
prone” stroma.  In all three cases, there was striking 
overlap with the collagen gene transcripts 
upregulated in Cav-1 (-/-) stromal cells, as indicated 
in bold (24 out of 35 transcripts; 12 out of 16 
transcripts; and 1 out of 1 transcript; See Table 1).  
 
Cav-1 (-/-) stromal cells have also been previously 
subjected to extensive analysis via an unbiased 
proteomics approach [8, 24].   We next intersected these 
proteomic results with the three human breast cancer 
stromal gene lists.  The results of this intersection are 
shown in Table 2. Note that many of the proteins that 
are upregulated in Cav-1 (-/-) stromal cells are also 
transcriptionally upregulated in the stroma of human 
breast cancer patients. Most notably, there was a strong 
association between the metabolic enzymes that were 
upregulated in Cav-1 (-/-) stromal cells and the 
“recurrence-prone” and “metastasis-prone” stromal 














Validating the “Reverse Warburg Hypothesis” in 
human breast cancer stroma 
 
Recently, based on the unbiased proteomic and 
transcriptional analysis of Cav-1 (-/-) stromal cells, we 
have proposed that tumor stromal fibroblasts may 
undergo aerobic glycolysis [8]. We have termed this 
new idea the “Reverse Warburg Effect” [8].  
 
Transcriptional analysis of Cav-1 (-/-) stromal cells [9] 
indicated that the “Reverse Warburg Effect” is 
associated with transcriptional over-expression of 
glycolysis-associated genes, HIF-target genes [25], NF-
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mitant compensatory transcriptional upregulation of 
























































Tumor Stroma Associated (24 of 35 collagen genes)        P-value 
Col11a1    collagen, type XI, alpha 1                         1.51e-73 
Col8a1   collagen,  type  VIII,  alpha  1        1.11e-51 
Col10a1                  collagen, type X, alpha 1                        2.37e-42 
Col12a1    collagen, type XII, alpha 1                         6.40e-34 
Col5a2   collagen,  type  V,  alpha  2        7.78e-33 
Col5a1   collagen,  type  V,  alpha  1        2.54e-31 
Col1a2   collagen,  type  I,  alpha  2        1.07e-27 
Col3a1   collagen,  type  III,  alpha  1        3.32e-27 
Col4a5   collagen,  type  IV,  alpha  5        6.04e-23 
Col8a2   collagen,  type  VIII,  alpha  2        1.78e-22 
Col6a3   collagen,  type  VI,  alpha  3        3.87e-19 
Col6a1   collagen,  type  VI,  alpha  1        8.97e-19 
Col9a1   collagen,  type  IX,  alpha  1        3.05e-18 
Col17a1    collagen, type XVII, alpha 1                        4.11e-18 
Col4a6   collagen,  type  IV,  alpha  6        2.50e-17 
Col1a1   collagen,  type  I,  alpha  1        3.20e-17 
Col25a1    collagen, type XXV, alpha 1                        7.13e-17 
Col5a3   collagen,  type  V,  alpha  3        1.17e-16 
Col20a1    collagen, type XX, alpha 1                         2.35e-16 
Col16a1    collagen, type XVI, alpha 1                        3.77e-16 
Col13a1    collagen, type XIII, alpha 1                         4.27e-14 
Col24a1    collagen, type XXIV, alpha 1                       4.07e-13 
Col15a1    collagen, type XV, alpha 1                         2.00e-12 
Col4a4    collagen, type IV, alpha 4                         5.55e-12 
Col4a2   collagen,  type  IV,  alpha  2        1.17e-11 
Col18a1    collagen, type XVIII, alpha 1         5.00e-11 
Col9a2   collagen,  type  IX,  alpha  2        5.30e-11 
Col14a1    collagen, type XIV, alpha 1                        4.92e-10 
Col23a1   collagen,  type  XXIII,  alpha  1       7.52e-08 
Col11a2    collagen, type XI, alpha 2                        3.90e-07 
Col2a1   collagen,  type  II,  alpha  1        6.22e-07 
Col27a1   collagen,  type  XXVII,  alpha  1     4.93e-06 
Col4a3   collagen,  type  IV,  alpha  3        1.21e-05 
Col19a1    collagen, type XIX, alpha 1                        1.90e-05 
Col4a1   collagen,  type  IV,  alpha  1        4.37e-02 
 
Recurrence-Prone Stroma (12 of 16 collagen genes) 
Col13a1    collagen, type XIII, alpha 1                         4.16e-05 
Col20a1    collagen, type XX, alpha 1                         4.34e-05 
Col3a1   collagen,  type  III,  alpha  1        8.00e-05 
Col11a1    collagen, type XI, alpha 1                        2.84e-04 
Col1a1   collagen,  type  I,  alpha  1        2.46e-03 
Col11a2    collagen, type XI, alpha 2                        4.63e-03 
Col8a2   collagen,  type  VIII,  alpha  2        8.91e-03 
Col23a1   collagen,  type  XXIII,  alpha  1       1.05e-02 
Col4a2   collagen,  type  IV,  alpha  2        1.51e-02 
Col9a1   collagen,  type  IX,  alpha  1        1.58e-02 
Col4a5   collagen,  type  IV,  alpha  5        1.85e-02 
Col14a1    collagen, type XIV, alpha 1                        1.94e-02 
Col2a1   collagen,  type  II,  alpha  1        2.06e-02 
Col10a1    collagen, type X, alpha 1                        2.08e-02 
Col9a2   collagen,  type  IX,  alpha  2        2.97e-02 
Col19a1    collagen, type XIX, alpha 1                        3.90e-02 
 
Metastasis-Prone Stroma (1 of 1 collagen genes) 














































































































Capg    capping protein (actin filament), gelsolin-like 4.18e-38 4.07e-03   
Sparc  secreted acidic cysteine rich glycoprotein  1.49e-35   
Arhgdib    Rho, GDP dissociation inhibitor (GDI) beta  3.92e-32   
Gpd2  glycerol phosphate dehydrogenase 2, mitochondrial   1.39e-29   
Upp1  uridine phosphorylase 1   2.77e-28   
Col3a1  collagen, type III, alpha 1     3.30e-27 8.00e-05   
Col1a2  collagen, type I, alpha 2     1.07e-27   
Tpm1  tropomyosin 1, alpha     2.20e-26 5.23e-07   
Sh3bgrl3  SH3 domain binding glutamic acid-rich protein-like 3 4.35e-24   
Col1a1  collagen, type I, alpha 1     3.20e-17   2.46e-03   
Eef1d    eukaryotic translation elongation factor 1 delta (guanine 




Nme2  non-metastatic cells 2, protein (NM23B) expressed in  2.39e-09   
Sncg  synuclein, gamma (breast cancer-specific protein 1) 8.86e-08   
Ldhc  lactate dehydrogenase C     1.26e-07 1.78e-03   
Myl1  myosin, light chain 1, alkali; skeletal, fast 3.60e-07   
Gsn  gelsolin        6.30e-05   
Ckm    creatine kinase, muscle    3.88e-05   
Tpm2  tropomyosin 2, beta     1.38e-03 2.22e-03   
Cnn2  calponin 2    2.26e-02   
Fth1  ferritin, heavy polypeptide 1    2.72e-02   
Pdha1    pyruvate dehydrogenase E1 alpha subunit   2.85e-02   
Pgk1  phosphoglycerate kinase 1    3.21e-02   
Eno3  enolase 3, beta muscle    1.29e-03
Aldoa  aldolase A, fructose-bisphosphate    1.69e-03
Afp  alpha fetoprotein    3.06e-02
Pkm2  pyruvate kinase, muscle    3.73e-02
Alb  albumin    3.95e-02
Pgd  phosphogluconate dehydrogenase    4.19e-02
Serpinb2  serine (or cysteine) peptidase inhibitor, clade B, member 2   4.27e-02

















 Glycolysis  HIF  Targets  Mitochondrial  Genes NF-kB  Targets Ox  Stress Alzheimer’s 
Stromal Gene Set  
 
          
Tumor Stroma  19 213  233  199  51  676 
Recurrence-Prone  10 108  120  86  22  338 
Metastasis-Prone 7  42  68  32  9  145 
            
Numbers of intersecting gene transcripts are shown; See Supplemental Tables 7, 8, and 9 for detailed lists.  
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represented in tumor stroma, “recurrence-prone” 
stroma, and the “metastasis-prone” stroma of human 
breast cancer patients (See also Supplmental Tables 7, 
8, and 9 for detailed gene lists).  
 
It is important to note that these breast cancer stromal 
gene lists also include Cxcl12, a known HIF-target gene 
[25], that is transcriptionally-upregulated ~5-fold in 
Cav-1 (-/-) stromal cells [8].  
 
The “Reverse Warburg Effect” and similarities with 
Alzheimer’s disease 
 
We have previously shown that the transcriptional 
profiles of Cav-1 (-/-) stromal cells significantly ovelap 
with the transcriptional profiles obtained from the 
analysis of Alzheimers disease brain [9]. We believe 
this is functionally due to the activation of similar 
biological processes in both “The Reverse Warburg 
Effect” and Alzheimer’s disease [9], including oxidative 
stress, NO over-production (peroxynitrite formation), 
inflammation, hypoxia, and mitochondrial dysfunction 
[27].  
 
Thus, here, we independently evaluated the association 
between Alzheimer’s disease and human breast cancer 
tumor stroma. These transcriptional overlaps are 
enumerated in Table 3, and are illustrated schematically 
as Venn diagrams in Figure 2.  Detailed gene lists are 
provided in Supplemental Tables 7, 8, and 9. 
 
Interestingly, as predicted, the genes that are 
transcriptionally upregulated in Alzheimer’s disease 
significantly overlap with tumor stroma, “recurrence-
prone” stroma, and “metastasis-prone” stroma. This 
clearly functionally links Alzheimer’s disease with the 
human breast cancer tumor stroma.  
 
As with the gene profiles of Cav-1 (-/-) stromal cells, 
the Alzheimer’s disease profiles were most significantly 
associated with the “metastasis-prone” stromal gene set 
(p = 9 x 10
-5). 
 
Detailed analysis of the “Metastasis-Prone” stromal 
gene set 
 
Next, we examined the possible overlap of the 
“metastasis-prone” stromal gene set with other existing 
transcriptional profiles, using gene-set enrichment 
analysis.  
 
Our results are shown in Table 4.  Briefly, we see that 
the “metastasis-prone” stromal gene set is associated 
with a number of interesting biological processes, 
including cell cycle progression and survival, DNA 
damage/repair, scleroderma, “stemness”, aging and 
oxidative stress, Alzheimer’s disease, decreased DNA-
methylation, tamoxifen-resistance, metastasis, Myc-
associated target genes, inflammation (NF-kB/STAT), 
TGFbeta signaling and myofibroblast differentiation, 
hypoxia and HIF signaling, mitochondrial function, and 
liver-specific gene transcription.  
 
We have independently shown that many of these same 
biological processes are activated in Cav-1 (-/-) stromal 
cells [9], consistent with the idea that Cav-1 (-/-) 
stromal cells are a valid model for exploring the tumor-
promoting effects of an activated tumor stromal micro-
environment.  
 
Similarities of the Cav-1 (-/-) stromal gene set with 
transcriptional profiling data from ER-negative 
breast cancer 
 
A comparison of the Cav-1 (-/-) stromal cell gene set 
with other existing transcriptional profiles also shows 
significant overlap with ER-negative human breast 
cancer (p = 8.96 x 10
-10; BRCA_ER_NEG [28]). For 
this overlap analysis, UP genes from the Cav-1 (-/-) 
stromal data set with a fold-change of >2.0  (KO/WT) 
and a P value of <0.1 were utilized for comparison with 
existing gene sets in the data base. 
 
Interestingly, these tumors were not laser-capture 
micro-dissected, so this provides an indication that the 
Cav-1 (-/-) stromal gene set may also be well 
represented in the transcriptional profiles obtained from 
whole tumors. A HeatMap containing these intersecting 
genes is shown in Figure 3 (205 overlapping genes; FC 
>1.5; p <0.05). See also Supplementary Table 10.  
 
These include key overlapping genes associated with 
metabolism and glycolysis (Acot7, Acsl4, Eno1, Gapdh, 
Ldhb, Mtrf1l, Pfkl, Pgk1, Pgm2, Pgm3, Slc2a5, 
Slc2a6), hypoxia (Hyou1), the inflammatory response 
(Aif1, C3, Ccl5, Crlf3, Ifngr1, Il10ra, Irak1, Irf5, Isg20, 
Nfib, Nfkbie, Nos3, Tnfaip3, Tnfrsf21, Tnfsf13b, 
Traf1),  myofibroblast differentiation and the 
extracellular matrix (Actl6a, Capg, Col9a3, Dnmt3b, 
Mmp9, Myo10, Spock2, Tgfbi, Tgm1, Timp2), as well 
as  DNA-damage and repair (Ddit3, Rad54l).  These 
results are consistent with the existence of the “Reverse 
Warburg Effect” in ER-negative breast cancers.   
 
Interestingly, it has been previously demonstrated that 
key secreted inflammatory factors, such as Aif1 
(allograft inflammatory factor-1) (upregulated nearly 3-
fold in Cav-1 (-/-) stromal cells; Supplementary Table 
10) promote NFkB-activation, the paracrine growth of 
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in the pathogenesis of pro-fibrotic diseases, such as 
scleroderma (systemic sclerosis) [30-32].  
 
Similarly, Aif1 expression is highly-upregulated in the 
tumor stroma of human breast cancers (See 
















































Here, we provide compelling transcriptional evidence 
for the “Reverse Warburg Effect” in human breast 
cancer tumor stroma. Using an unbiased informatics 
analysis of transcriptional gene profiling, we show that 
Cav-1 (-/-) stromal cells bear a striking resemblance to 
the activated tumor stroma of human breast cancers. 
More specifically, the transcriptional profiles of Cav-1 
(-/-) stromal cells were most closely related to the 
stroma of breast cancer patients that had undergone LN-
metastasis. This is consistent with our previous data 
showing that a loss of stromal Cav-1 protein expression 
(by immuno-histochemistry) in human breast cancer 
tumor micro-arrays is specifically associated with 
increased LN-metastasis [3,4].   
 
Moreover, we provide evidence that the tumor stroma 
of human breast cancers shows a transcriptional shift 
towards oxidative stress, DNA damage/repair, 
inflammation, hypoxia, and aerobic glycolysis. These 
findings are consistent with the “Reverse Warburg 
Effect” [8,9]. Notably, the tumor stroma of “metastasis-
prone” breast cancer patients was also closely related to 
the transcriptional profiles derived from the brains of 
patients with Alzheimer’s disease. As such, certain 
fundamental biological processes are common to both 
an activated tumor stroma and neuro-degenerative 
stress.  These key biological processes most likely 
include oxidative stress, NO over-production 
(peroxynitrite formation), inflammation, hypoxia, and 
mitochondrial dysfunction, which are all thought to 
drive Alzheimer’s disease pathogenesis.  
 
Thus, we avidly reviewed the literature regarding 
theories of neuronal functioning, neuronal stress, and 
neuro-degeneration, in the central nervous system and 
we stumbled upon the idea of “Neuron-Glia Metabolic 
Coupling” [11-18]  In this model, first proposed over 10 
years ago, astrocytes shift towards aerobic glycolyis, 
secrete pyruvate and lactate, which is then taken-up by 
adjacent neurons and then “feeds” into the neuronal 
TCA cycle, resulting in increased neuronal oxidative 
mitochondrial metabolism, and higher ATP production 
Figure  2.  Venn  diagrams  for  the  transcriptional 











in neurons. In essence, the astrocytes would function as 
support cells to “feed” the adjacent neuronal cells. Thus, 
“Neuron-Glia Metabolic Coupling” and the “Reverse 
Warburg Effect” are analogous biological processes, 
where the astrocytes are the cancer-associated fibroblasts 
and the neurons are the epithelial tumor cells.  As such, 
we propose that the “Reverse Warburg Effect” could also 
be more generally termed “Epithelial-Stromal Metabolic 


















































































































Table 4. Overlap of the LN metastasis-prone stromal data set with other existing gene data sets 
 
D a t a   S e t      D e s c r i p t i o n                     P - v a l u e    
 
Cell Cycle Progression and Survival 
MORF_ANP32B      Neighborhood of ANP32B acidic (leucine-rich) nuclear phosphoprotein 32 family, member B      2.34E-08       
in the MORF expression compendium 
MORF_CSNK2B       Neighborhood of CSNK2B casein kinase 2, beta polypeptide in the MORF expression compendium   3.97E-06 
MORF_PCNA       Neighborhood of PCNA proliferating cell nuclear antigen in the MORF expression compendium      6.66E-06 
MORF_DEK       Neighborhood of DEK oncogene (DNA binding) in the MORF expression compendium        4.97E-05 
SHIPP_FL_VS_DLBCL_DN   Genes upregulated in diffuse B-cell lymphomas (DLBCL) and downregulated in follicular                   1.17E-04 
lymphoma (FL) (fold change of at least 3) 
MORF_RAN       Neighborhood of RAN, member RAS oncogene family in the MORF expression compendium      2.14E-04 
MORF_SKP1A       Neighborhood of SKP1A S-phase kinase-associated protein 1A (p19A) in the MORF expression      2.28E-04 
Compendium 
TGANTCA_V$AP1_C     Genes with promoter regions [-2kb,2kb] around transcription start site containing the motif                 4.47E-04
                                                  TGANTCA which matches annotation for JUN: jun oncogene 
GNF2_RAN      Neighborhood of RAN, member RAS oncogene family in the GNF2 expression compendium     8.76E-04 
GCM_ANP32B      Neighborhood of ANP32B acidic (leucine-rich) nuclear phosphoprotein 32 family, member B in the     
GCM expression compendium   
MITOSIS      Genes annotated by the GO term GO:0007067. Progression through mitosis, the division of the      1.10E-02
                                                  eukaryotic cell nucleus to produce two daughter nuclei that, usually, contain the identical  
                                                                chromosome complement to their mother.                                 
SMITH_HTERT_UP    Genes upregulated by t e l o m e r a s e               1 . 9 0 E - 0 2  
CHANG_SERUM_RESPONSE_UP  CSR (Serum Response) signature for activated genes (Stanford)            2.13E-02 
 
DNA Damage and Repair 
CIS_XPC_UP       Increased expression in XPC-defective fibroblasts, compared to normal fibroblasts,        2.08E-07 
                                                                following treatment with cisplatin 
MORF_RAD23A       Neighborhood of RAD23A, RAD23 homolog A (S. cerevisiae) in the MORF expression       3.01E-07 
                                                                 compendium; nucleotide excision repair (NER) 
MORF_G22P1       Neighborhood of G22P1 NULL in the MORF expression compendium         6.29E-07 
a.k.a., XRCC6 Gene, X-ray repair complementing defective repair in Chinese hamster cells 6;  
a.k.a., thyroid autoantigen 70kD (Ku antigen) 
MORF_XRCC5       Neighborhood of XRCC5 X-ray repair complementing defective repair in Chinese hamster cells 5      2.48E-04 
                                                               (double-strand-break rejoining; Ku autoantigen, 80kDa) in the MORF expression compendium 
MORF_EIF3S6                    Neighborhood of EIF3S6 eukaryotic translation initiation factor 3, subunit 6 48kDa in the      3.61E-04 
MORF                                                    expression compendium; murine mammary tumor integration site 6 (oncogene homolog) 
GNF2_G22P1      Neighborhood of G22P1 NULL in the GNF2 expression compendium         4.90E-04 
MORF_RAD21      Neighborhood of RAD21 RAD21 homolog (S. pombe)  in the MORF expression compendium     1.28E-03 
UVC_LOW_A2_UP    Up-regulated at 6-12 hours following treatment of WS1 human skin fibroblasts with UVC at     3.90E-03 
a   l o w   d o s e   ( 1 0   J / m ^ 2 )   ( c l u s t e r   a 2 )           
UVB_NHEK3_C7     Regulated by UV-B light in normal human epidermal keratinocytes, cluster 7         6.80E-03 
UVC_LOW_ALL_UP    Up-regulated at any timepoint following treatment of WS1 human skin fibroblasts with UVC     7.84E-03
                                                  low dose (10 J/m^2) (clusters a1-a4)                 
UVB_NHEK3_C4     Regulated by UV-B light in normal human epidermal keratinocytes, cluster 4         9.69E-03 
UVB_NHEK1_C4                   Upregulated by UV-B light in normal human epidermal keratinocytes, cluster 4        9.75E-03        
UVB_NHEK3_ALL    Regulated by UV-B light in normal human epidermal keratinocytes           1.00E-02 
 
Scleroderma 
MORF_FBL       Neighborhood of FBL fibrillarin in the MORF expression compendium           7.49E-07 
                                                    a.k.a., 34 kDa nucleolar scleroderma antigen, or RNA, U3 small nucleolar 
 interacting protein 1 
Stem Cells 
STEMCELL_NEURAL_UP    Enriched in mouse neural stem cells, compared to differentiated brain and bone marrow cells      6.93E-06 
STEMCELL_EMBRYONIC_UP Enriched  in  mouse embryonic stem cells, compared to differentiated brain and bone marrow cells      1.97E-04 
LIN_WNT_UP      Genes up-regulated by APC in  SW480  (colon  cancer)              7.50E-04 
HSC_INTERMEDIATE 
PROGENITORS_FETAL    Up-regulated in mouse hematopoietic intermediate progenitors from fetal liver (Intermediate      3.75E-03 
                                                                Progenitors Shared + Fetal) 
HSA04310_WNT_SIGNALING 
_PATHWAY    Genes  involved in Wnt signaling pathway               7.14E-03      
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HSA04330_NOTCH_SIGNALING_    Genes involved in Notch  signaling  pathway       1.28E-02              
PATHWAY 
V$TCF4_Q5      Genes with promoter regions [-2kb,2kb] around transcription start site containing the motif   1.49E-02 
SCTTTGAW which matches annotation for TCF4: transcription factor 4 
HSC_HSCANDPROGENITORS Up-regulated in mouse hematopoietic stem cells and progenitors from both adult bone marrow and  2.00E-02 
_SHARED                                              fetal liver (Cluster iii, HSC and Progenitors Shared)             
HSC_HSCANDPROGENITORS_   Up-regulated in mouse hematopoietic stem cells and progenitors from fetal liver (HSC and  2.09E-02  
FETAL       Progenitors  Shared) 
HSC_INTERMEDIATEPRO- Up-regulated in mouse hematopoietic intermediate progenitors from both adult bone marrow and  2.15E-02 
GENITORS_SHARED    fetal liver (Cluster v, Intermediate  Progenitors  Shared)        
MAMMARY_DEV_UP    Up-regulated in the intact developing mouse mammary gland; higher expression in 5/6 week   2.15E-02 
        pubertal glands than in 3 week, mid-pregnant, lactating, involuting or resuckled glands   
Aging, Alzheimer’s Disease, and Oxidative Stress 
MORF_SOD1       Neighborhood of SOD1 superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult))   1.98E-05 
in the MORF expression compendium           
ALZHEIMERS_DISEASE_UP  Upregulated in correlation with overt Alzheimer's Disease, in the CA1 region of the hippocampus   9.05E-05 
MORF_JUND      Neighborhood of JUND jun D proto-oncogene  in the MORF expression compendium    2.87E-03 
 
Regulation of DNA Methylation 
MORF_HDAC1       Neighborhood of HDAC1 histone deacetylase 1 in the MORF expression compendium     9.91E-06 
TSA_PANC50_UP     50 most interesting genes upregulated by TSA treatment in at least one of four pancreatic cancer   4.32E-04 
cell lines, but not in normal (HPDE) cells 
MORF_HAT1      Neighborhood of HAT1 histone acetyltransferase 1 in the MORF expression compendium  9.44E-04 
 
Breast Cancer Associated Tamoxifen-Resistance 
MORF_NPM1       Neighborhood of NPM1 nucleophosmin (nucleolar phosphoprotein B23, numatrin) in the MORF   1.73E-04 
expression compendium 
GCM_NPM1      Neighborhood of NPM1 nucleophosmin (nucleolar phosphoprotein B23, numatrin)  in the GCM   7.21E-03  
expression compendium 
GNF2_NPM1    Neighborhood  of  NPM1          1.24E-02 
 
Metastasis 
MORF_NME2      Neighborhood of NME2 non-metastatic cells 2, protein (NM23B) expressed in  in the MORF   2.04E-03 
expression compendium   
MORF_MTA1      Neighborhood of MTA1 metastasis associated 1  in the MORF expression compendium    1.28E-02 
CROMER_HYPOPHARYNGEAL_ 
MET_VS_NON_UP    Genes increased in metastatic  hypopharyngeal  cancer  tumours     2.37E-02   
 
Myc-Associated Genes  
CACGTG_V$MYC_Q2    Genes with promoter regions [-2kb,2kb] around transcription start site containing the motif   2.05E-03 
CACGTG which matches annotation for MYC: v-myc myelocytomatosis viral oncogene homolog 
LEE_MYC_TGFA_UP    Genes up-regulated in hepatoma tissue of Myc+Tgfa transgenic mice       7.34E-03 
LEE_MYC_UP      Genes up-regulated in hepatoma tissue of Myc transgenic mice        1.00E-02 
MYC_ONCOGENIC_SIGNATURE  Genes selected in supervised analyses to discriminate cells expressing c-Myc oncogene from   1.00E-02 
control cells expressing GFP.  
V$MYC_Q2      Genes with promoter regions [-2kb,2kb] around transcription start site containing the motif   1.26E-02 
CACGTGS which matches annotation for MYC: v-myc myelocytomatosis viral oncogene homolog  
V$NMYC_01      Genes with promoter regions [-2kb,2kb] around transcription start site containing the motif   1.32E-02 
NNCCACGTGNNN which matches annotation for MYCN: v-myc myelocytomatosis viral related  
oncogene, neuroblastoma derived (avian) 
FERNANDEZ_MYC_TARGETS  MYC target genes by ChIP in U-937,HL60 (leukemia),P493 (B-cell),T98G (glioblastoma),WS1   2.43E-02  
(fibroblast) 
   






































If these two processes are indeed analogous, then 
epithelial tumor cells have already learned to behave as 
neurons, using the stroma as a means of support and 
nourishment. Figure 4 directly compares “Neuron-Glia 
Metabolic Coupling” with the “Reverse Warburg 
effect” schematically.  
 
Myofibroblasts and mesenchymal stem cells are known 
to often express GFAP (glial fibrillary acidic protein) 
[19-21], an intermediate filament protein that is thought 
to be relatively specific for astrocytes in the central 
nervous system.  Table 5 shows that GFAP and other 
glial-related gene transcripts are indeed upregulated in 
“tumor stroma” and in the stroma of “metastasis-prone” 
breast cancer patients. Thus, possible metabolic and 








































IL6_FIBRO_UP    Upregulated  following  IL-6  treatment in normal skin fibroblasts        2.05E-03  
TNFALPHA_30MIN_UP    Upregulated 30min after TNF-alpha treatment of HeLa cells        2.23E-03 
HESS_HOXAANMEIS1_UP   Genes upregulated in Hoxa9/Meis1 transduced cells  vs  control     6.31E-03 
ST_INTERLEUKIN_13_PATHWAY  IL-13 is produced by Th2 cells on activation of the T cell antigen receptor, and by mast and   9.22E-03  
basophil cells on activation of the IgE receptor. 
ST_IL_13_PATHWAY    Like IL-4, IL-13 is produced by Th2 cells on activation of the T cell antigen receptor, and by mast  9.45E-03 
and basophil cells on activation of the IgE receptor.   
V$IRF_Q6      Genes with promoter regions [-2kb,2kb] around transcription start site containing the motif   1.42E-02  
BNCRSTTTCANTTYY which matches annotation for IRF1: interferon regulatory factor 1   
TNFALPHA_ALL_UP    Upregulated at any timepoint after TNF-alpha treatment of HeLa cells      1.44E-02 
  
 
TGFbeta Signaling/Myofibroblast Differentiation/Fibrosis 
GCM_ACTG1      Neighborhood of ACTG1 actin, gamma 1  in the GCM expression compendium    2.18E-03 
TGFBETA_ALL_UP    Upregulated by TGF-beta treatment of skin fibroblasts, at any timepoint      6.80E-03 
MYOD_BRG1_UP    Genes  up-regulated  following  transduction of MyoD in NIH 3T3 cells that fail to acheive full   7.07E-03 
induction with expression of a dominant-negative BRG1 allele 
MORF_ACTG1      Neighborhood of ACTG1 actin, gamma 1  in the MORF expression compendium    9.15E-03 
MYOD_NIH3T3_UP    Up-regulated at 24 hours in NIH 3T3 murine fibroblasts following transduction with MyoD and   1.08E-02 
incubation in differentiation medium   
POMEROY_DESMOPLASIC_VS_ 
CLASSIC_MD_UP    Genes expressed in desmoplastic medulloblastomas. (p < 0.01)         9.68E-03 
TGFBETA_LATE_UP    Upregulated by TGF-beta treatment of skin fibroblasts only at 1-4 hrs (clusters 4-6)    2.36E-02 
  
 
Hypoxia/HIF Signaling/Mitochondrial Genes/Metabolism 
HYPOXIA_REVIEW   Genes  known  to  be  induced  by  hypoxia        8.96E-03 
HIF1_TARGETS    Hif-1  (hypoxia-inducible  factor  1)  transcripional  targets      1.07E-02 
HUMAN_MITODB_6_2002   Mitochondrial  genes         1.08E-02 
MITOCHONDRIA    Mitochondrial  genes         1.28E-02 
HYPOXIA_RCC_UP   Upregulated  by  hypoxia in VHL-rescued renal carcinoma cells (Fig. 3f+g)       1.42E-02 
HSA00330_ARGININE_AND_ 
PROLINE_METABOLISM    Genes involved in arginine  and  proline  metabolism      2.20E-02 
 
Liver Specific Transcription 




fibroblasts/cancer-associated fibroblasts should be 
further explored.  
 
Interestingly, in “Neuron-Glia Metabolic Coupling” 
the glycolytic shift in astrocytes is thought to be 
mediated by the secretion of glutamate (a 
neurotransmitter) from neurons. Then, astrocytes take 
up glutamate via high affinity sodium-dependent 
glutamate transporters, such as Slc1a2 and Slc1a3. 
Importantly, one of these two glial-specific glutamate 
transporters (Slc1a3) is also transcriptionally over-
expressed in the stroma of human breast cancer 
patients (Table 5). As such, the  similarities between 
brain astrocytes, myofibroblasts, mesenchymal stem 
cells, and tumor stromal cells may be more extensive 
than we previously appreciated. 
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Gcm1  glial cells missing homolog 1 (Drosophila)  6.50e-21  8.39e-04   
 
Gfap  glial fibrillary acidic protein     1.64e-18  1.36e-03  2.28e-02 
 
Gfra2  glial cell line derived neurotrophic factor 
family receptor alpha 2 
2.28e-17 3.58E-02   
  
Slc1a3  solute carrier family 1 (glial high affinity 
glutamate transporter), member 3 
4.22e-17 5.70e-03   
 
Gfra3  glial cell line derived neurotrophic factor 
family receptor alpha 3 




glial cell line derived neurotrophic factor  6.48e-14     
Gcm2  glial cells missing homolog 2 (Drosophila)  1.38e-05  2.06e-02   
Gfra4  glial cell line derived neurotrophic factor 
receptor alpha 4 
























































METHODS OF ANALYSIS 
 
Venn diagrams. In the Venn diagram of Figure 1, we 
show the intersections between the set of genes that are 
upregulated in Cav-1 (-/-) versus wild-type stromal cells 
[8] and three breast cancer gene sets [10]. 
 
(a)  the set of stromal genes that are upregulated in 
breast cancer tumor patients versus normal breast 
stroma;   
(b)  the set of stromal genes that are upregulated in 
recurrence positive versus recurrence negative breast 
cancer patients 
(c)  the set of stromal genes that are upregulated in 
lymph-node metastasis positive versus lymph-node 
metastasis negative breast cancer patients. 
 
In the Venn diagram of Figure 2, we show the 
intersections between the set of genes that are 
upregulated in Alzheimer’s brain disease [22] and the 
sets of genes (a)-(c) listed above. The p-values 
determining the significance of upregulation for each 
gene were computed using a one-sided t-test statistic 
(Tables 1, 2, and 5). For each pair (X,Y) of sets of 
genes, we also computed the probability (p-value) that 
the size of their intersection is less than or equal to the 
size of the intersection between set X and a randomly-
chosen set of size equal to the size of set Y. This 
probability was calculated by applying the cumulative 
density function of the hypergeometric distribution on 
the size of set X, the size of set Y, the observed overlap 
between X and Y, and the total number of available 
genes. 
 
Gene set enrichment analysis. For the functional 
analysis presented in Table 4, we used data from the 
Molecular Signatures Database (MsigDB [23]) which 
comprises a collection of gene sets:  
Figure 4. Comparisons between the “Reverse Warburg Effect”
and  “Neuron‐Glia  Metabolic  Coupling”,  suggest  “Epithelial‐
Stromal  Metabolic  Coupling”.  In  “Neuron‐Glia  Metabolic
Coupling”,  astrocytes  take  up  more  glucose,  shift  towards
aerobic  glycolyis,  secrete  pyruvate  and  lactate,  which  is  then
taken  up  by  adjacent  neurons  and  then  “feeds”  into  the
neuronal  TCA  cycle,  resulting  in  increased  neuronal  oxidative
mitochondrial  metabolism,  and  higher  ATP  production  in
neurons. In essence, the astrocytes function as support cells to









- collected from various sources such as online pathway 
databases, publications, and knowledge of domain 
experts,  
- comprising genes that share a conserved cis-regulatory 
motif across the human, mouse, rat, and dog genomes,  
- identified as co-regulated gene clusters by mining 
large collections of cancer-oriented microarray data, and 
- annotated by a common Gene Ontology (GO) term. 
 
For our analysis we used the latest release of MSigDB 
database v2.5 (April 7, 2008), after converting all the 
gene names in the database into RefSeq gene IDs. After 
this preprocessing step, we chose the sub-collection of 
gene sets that was relevant to our study, and for each 
gene set X in that sub-collection, we computed the 
overlap between X and the set of genes Y that are 
upregulated in lymph-node metastasis positive versus 
lymph-node metastasis negative breast cancer patients 
(p-value ≤0.05). Then, we computed the probability (p-
value) of the observed overlap between sets X and Y as 
described in the “Venn diagrams” section. 
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